Clinical - ABL SA : ABL SA

Read more

EMRs - Registries - Integration tool

Read more

Clinical solutions

Discover our solutions

Clinical applications

Discover our applications

Meet ABL at MEDICA for Leveraging your Infectious Diseases Genotyping Capacities?

Oct 21, 2019

Meet us at MEDICA 2019 for Leveraging your Infectious Diseases Genotyping Capacities Good morning, ABL will be attending the next MEDICA forum in Düsseldorf from 18 – 21 November 2019 (Hall 3 / A74). We will be pleased to have a chance to meet you there and explain you in detail the SA…
Read more
TGEN AND ABL PLAN GLOBAL ROLLOUT OF ADVANCED TEST FOR TB, ONE OF THE WORLD’S MOST DEADLY PATHOGENS

Aug 01, 2019

FLAGSTAFF, Ariz., and LUXEMBOURG CITY, Luxembourg — Aug. 31 — Advanced Biological Laboratories (ABL) is expected to soon begin manufacturing of a compact, portable and affordable test for tuberculosis (TB), designed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hop…
Read more
Connexion du logiciel ViroScore®-HIV (CE IVD) à Nadis disponible

Jul 26, 2019

Nous avons le plaisir de vous annoncer que l’intégration du logiciel ViroScore®-HIV (CE IVD) à la plateforme Nadis est disponible. Cette intégration permet à l’ensemble des utilisateurs Nadis de bénéficier de fonctionnalités avancées pour le génotypage du VIH: Synchronisation bidirectionnelle des do…
Read more

ABL Announces Distribution Agreement with Hydrox SIA in Latvia

Jul 01, 2019

Advanced Biological Laboratories (ABL) S.A. and ILC – Hydrox SIA are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Latvia. See current channel partners.
Read more
Connection du logiciel ViroScore®-HIV (CE IVD) à Nadis bientôt disponible

Apr 08, 2019

Nous avons le plaisir de vous annoncer que l’intégration du logiciel ViroScore®-HIV (CE IVD) à la plateforme Nadis est bientôt disponible. Cette intégration va permettre à l’ensemble des utilisateurs Nadis de bénéficier de fonctionnalités avancées pour le génotypage du VIH telles que l…
Read more
MicrobioChek – An innovative software system for micro-organisms analysis and clinical interpretation

Mar 26, 2019

ABL is pleased to announce the development and future release of the first version of MicrobioChek, a generic downstream analysis software intended to be used by microbiology laboratories for micro-organism related molecular analysis. Developed with the support of a RDI grant from the Ministry of th…
Read more

TGen and ABL pursue global rollout of advanced TB test

Mar 19, 2019

FLAGSTAFF, Ariz., LUXEMBOURG City, Luxembourg — In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories (ABL…
Read more
Advanced Biological Laboratories, Mayo Clinic Laboratories collaborate on test development to help patients with cytomegalovirus infection

Mar 14, 2019

LUXEMBOURG VILLE, Luxembourg, and ROCHESTER, Minn. – Advanced Biological Laboratories (ABL), S.A., a Luxembourg-based diagnostics company and leader in virology genotyping, and Mayo Clinic Laboratories have announced a collaboration. The two organizations are working together to develop a clinical t…
Read more
IntegraGen and Advanced Biological Laboratories sign global licensing agreement for the commercialization of miRpredX test

Mar 04, 2019

ÉVRY, France and LUXEMBOURG City, Luxembourg (February 27th, 2019) – IntegraGen, a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, and Advanced Biological Laboratories (ABL), a leading integrated diagnostics…
Read more